BUY Avalon Technologies Limited — Macquarie
byMacquarieHorizon: 1 year7 Aug 2026via Financial Express Market
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
EMS Stock in Which FIIs Are Accumulating as It Diversifies Into Clean Energy, Railways and Aerospace
NewsGoogle News·8 Aug · 1w ago
Avalon Technologies Limited announced its financial results for Q1 FY27, reporting a 49.8% YoY increase in revenue and a 145.3% YoY increase in PAT. Key highlights include an 8th consecutive quarter o
NSE · Press Release·4 Aug · 2w ago
1 other SEBI-registered advisor has an active long-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·5 Aug · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Avalon Technologies
- BUY — Motilal Oswal12 Oct 2026 · ~1 year · target ₹2,529 · Active
- BUY — Ashish Chaturmohta, JM Financial7 Oct 2026 · ~2 weeks · target ₹2,800 · SL hit
- BUY — Rakesh Bansal18 Sept 2026 · ~2 weeks · target ₹2,500 · Target hit
- BUY — Motilal Oswal8 Sept 2026 · ~1 year · target ₹2,740 · Active
- BUY — Nilesh Jain, Centrum Broking7 Sept 2026 · ~3 months · target ₹2,500 · SL hit
More from Macquarie
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹860 · Active
- BUY Oil and Natural Gas Corporation15 Oct 2026 · ~1 year · target ₹260 · Active
- BUY Hitachi Energy India12 Oct 2026 · ~1 year · target ₹38,500 · Active
- BUY Titan Company7 Oct 2026 · ~1 year · target ₹5,600 · Active
- SELL Mankind Pharma7 Oct 2026 · ~1 year · target ₹2,200 · Active

